Business Description
ChromoGenics AB
ISIN : SE0020847481
Description
Financial Strength
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.19 | |||||
Equity-to-Asset | 0.53 | |||||
Debt-to-Equity | 0.37 | |||||
Debt-to-EBITDA | -3 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | -7.41 | |||||
Beneish M-Score | -2.88 | |||||
WACC vs ROIC |
Growth Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -51.4 | |||||
3-Year EBITDA Growth Rate | 53 | |||||
3-Year EPS without NRI Growth Rate | 63.7 | |||||
3-Year FCF Growth Rate | 58.5 | |||||
3-Year Book Growth Rate | -65.9 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 62.12 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 60.52 | |||||
9-Day RSI | 56.95 | |||||
14-Day RSI | 54.73 | |||||
6-1 Month Momentum % | 55.17 | |||||
12-1 Month Momentum % | 52.83 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.68 | |||||
Quick Ratio | 0.4 | |||||
Cash Ratio | 0.14 | |||||
Days Inventory | 356.87 | |||||
Days Sales Outstanding | 116.87 | |||||
Days Payable | 134.52 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -107.4 | |||||
Shareholder Yield % | -42.11 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | -33.03 | |||||
Operating Margin % | -161.01 | |||||
Net Margin % | -221.29 | |||||
FCF Margin % | -505.8 | |||||
ROE % | -37.28 | |||||
ROA % | -13.2 | |||||
ROIC % | -9.95 | |||||
3-Year ROIIC % | 84.91 | |||||
ROC (Joel Greenblatt) % | -13.36 | |||||
ROCE % | -11.89 |
GF Value Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 4.81 | |||||
PB Ratio | 0.95 | |||||
Price-to-Tangible-Book | 1.12 | |||||
EV-to-EBIT | -6.48 | |||||
EV-to-EBITDA | -10.31 | |||||
EV-to-Revenue | 10.15 | |||||
EV-to-FCF | -2 | |||||
Earnings Yield (Greenblatt) % | -15.44 | |||||
FCF Yield % | -65.06 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
ChromoGenics AB Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 0.742 | ||
EPS (TTM) (€) | -0.604 | ||
Beta | 5.24 | ||
Volatility % | 276.78 | ||
14-Day RSI | 54.73 | ||
14-Day ATR (€) | 0.019039 | ||
20-Day SMA (€) | 0.8321 | ||
12-1 Month Momentum % | 52.83 | ||
52-Week Range (€) | 0.329 - 1.125 | ||
Shares Outstanding (Mil) | 6.63 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
ChromoGenics AB Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
ChromoGenics AB Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
ChromoGenics AB Frequently Asked Questions
What is ChromoGenics AB(STU:384)'s stock price today?
When is next earnings date of ChromoGenics AB(STU:384)?
Does ChromoGenics AB(STU:384) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |